|
2022
|
Invention
|
Compositions and methods for determining resistance to inhibitors of virus enter using recombinan... |
|
2020
|
Invention
|
Compositions and methods for determining resistance to inhibitors of virus entry using recombinan... |
|
2019
|
Invention
|
Methods for determining resistance or susceptibility to hiv entry inhibitors. The invention provi... |
|
2017
|
Invention
|
Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus ... |
|
2016
|
Invention
|
Methods for determining susceptibility to coreceptor inhibitors. The invention provides a method ... |
|
2015
|
Invention
|
Methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recom... |
|
|
Invention
|
Methods and compositions for analyzing proteins. Compositions, kits, and methods are disclosed fo... |
|
2012
|
Invention
|
Methods for determining hypersusceptibility of hiv-1 to non-nucleoside reverse transcriptase inhi... |
|
|
Invention
|
Molecular determinants in the hiv-1 envelope associated with enhanced ability to enter cxcr4-expr... |
|
|
Invention
|
Methods for detecting receptor complexes comprising pi3k. The invention is directed to a new clas... |
|
2011
|
Invention
|
Methods and compositions for determining altered susceptibility of hiv-1 to anti-hiv drugs. This ... |
|
|
Invention
|
Compositions for analyzing proteins. Methods, compositions and kits are disclosed for determining... |
|
|
Invention
|
Detection of activation of endothelial cells as surrogate marker for angiogenesis.
Methods, comp... |
|
2009
|
Invention
|
Methods for determining the presence of antibodies blocking viral infection. The present inventio... |
|
2008
|
Invention
|
Her2 diagnostic methods. In certain aspects, the present invention provides methods for determini... |
|
|
Invention
|
Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy.
The invention pro... |
|
|
Invention
|
Detecting and profiling molecular complexes.
Methods are provided for detecting the formation of... |
|
|
Invention
|
Measuring receptor homodimerization. The invention provides methods and kits for detecting and/or... |
|
|
Invention
|
Electrophoretic tag-based in vitro assay to quantify dimerization of p66 and p51 sub-units of hiv... |
|
|
Invention
|
Electrophoretic tag-based in vitro assay to quantify dimerization of p66 and p51 subunits of hiv-... |
|
|
Invention
|
Compositions and methods for determining whether a subject would benefit from co-receptor inhibit... |
|
|
Invention
|
Methods and compositions for determining altered susceptibility of hiv-1 to protease inhibitor tr... |
|
2007
|
Invention
|
Erbb heterodimers as biomarkers.
A method of determining the status of a disease or healthful co... |
|
|
Invention
|
Surface receptor complexes as biomarkers.
The invention is directed to a new class of biomarker ... |
|
|
Invention
|
Methods and compositions for analyzing proteins.
Methods, compositions and kits are disclosed fo... |
|
|
Invention
|
Method for determining human immunodeficiency virus (hiv) coreceptor utilization by examining gp4... |
|
|
Invention
|
Molecular determinants associated with enhanced ability to enter cells expressing cxcr4. The inve... |
|
|
Invention
|
Microfluidic analytical apparatus. A microfluidic analytical apparatus (10) comprising a microflu... |
|
|
Invention
|
Detecting and profiling molecular complexes. Methods are provided for detecting the formation of ... |
|
|
Invention
|
Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeuti... |
|
|
Invention
|
Method for determining resistance of hiv to protease inhibitor treatment.
The present invention ... |
|
|
Invention
|
Method for determining resistance of hiv to protease inhibitor treatment. The present invention p... |
|
2006
|
Invention
|
Single cell analysis of membrane molecules.
Interrogation of surface receptors of individual cel... |
|
|
Invention
|
Analyte identification in transformed electropherograms.
The present invention is directed to me... |
|
|
P/S
|
Diagnostic agents for medical purposes; assays for medical use in testing of blood, and for assis... |
|
|
Invention
|
Compositions and methods for determining susceptibility of hepatitis c virus to anti-viral drugs.... |
|
|
Invention
|
Methods and compositions for determining resistance of hiv-1 to protease inhibitors.
This invent... |
|
|
Invention
|
Method for determining resistance of hiv to nucleoside reverse transcriptase inhibitor treatment.... |
|
|
Invention
|
Detecting molecular complexes. The invention provides methods and compositions for detecting the ... |
|
|
Invention
|
Methods and compositions for determining anti-hiv drug susceptibility and replication capacity of... |
|
|
Invention
|
Methods and compositions for determining hypersusceptibility of hiv-1 to non-nucleoside reverse t... |
|
2005
|
Invention
|
Response predictors for erbb pathway-specific drugs.
The invention provides a method of determin... |
|
|
P/S
|
Medical testing and diagnostic laboratory services and development of therapy guidance tools, nam... |
|
2002
|
Invention
|
Method of evaluating a patient antibody response to envelope proteins of a virus. The invention p... |
